Process View
The process in which the anatomical structures of a branched epithelium are generated and organized.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "morphogenesis of a branching epithelium"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| FGFR2 | fibroblast growth factor receptor 2 | 0.972 | Mouse Fly | |
| VEGFA | vascular endothelial growth factor A | 0.955 | Mouse | |
| RARA | retinoic acid receptor, alpha | 0.943 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.931 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.849 | Mouse Fly | |
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.838 | Mouse | |
| FGF1 | fibroblast growth factor 1 (acidic) | 0.752 | ||
| NRP1 | neuropilin 1 | 0.694 | Mouse | |
| CREBBP | CREB binding protein | 0.615 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.595 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.569 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.548 | ||
| THBS1 | thrombospondin 1 | 0.536 | ||
| COL4A2 | collagen, type IV, alpha 2 | 0.500 | Human | |
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.491 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.457 | ||
| BCL2L1 | BCL2-like 1 | 0.439 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.426 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.351 | Mouse Fly | |
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.325 | Mouse | |
| COL2A1 | collagen, type II, alpha 1 | 0.311 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.303 | ||
| TBX5 | T-box 5 | 0.293 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.246 | ||
| FGF10 | fibroblast growth factor 10 | 0.245 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.237 | Mouse | |
| FN1 | fibronectin 1 | 0.230 | ||
| NKX2-1 | NK2 homeobox 1 | 0.213 | ||
| GAS6 | growth arrest-specific 6 | 0.212 | ||
| PTPN12 | protein tyrosine phosphatase, non-receptor type 12 | 0.211 | ||
| JAG1 | jagged 1 | 0.200 | ||
| FGF2 | fibroblast growth factor 2 (basic) | 0.189 | ||
| EIF2C2 | eukaryotic translation initiation factor 2C, 2 | 0.151 | ||
| COL4A3 | collagen, type IV, alpha 3 (Goodpasture antigen) | 0.148 | Human | |
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.146 | ||
| HOXA10 | homeobox A10 | 0.145 | ||
| RUNX1 | runt-related transcription factor 1 | 0.140 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.137 | ||
| PTK2 | PTK2 protein tyrosine kinase 2 | 0.137 | ||
| ITGB4 | integrin, beta 4 | 0.136 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.135 | ||
| MEIS1 | Meis homeobox 1 | 0.124 | ||
| COL4A4 | collagen, type IV, alpha 4 | 0.120 | Human | |
| PAX8 | paired box 8 | 0.120 | ||
| BMP7 | bone morphogenetic protein 7 | 0.118 | Human Mouse | |
| CTNNA1 | catenin (cadherin-associated protein), alpha 1, 102kDa | 0.116 | ||
| PKD2 | polycystic kidney disease 2 (autosomal dominant) | 0.115 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.112 | ||
| SMN1 | survival of motor neuron 1, telomeric | 0.111 | ||
| PTPN11 | protein tyrosine phosphatase, non-receptor type 11 | 0.110 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.109 | ||
| PGF | placental growth factor | 0.105 | Mouse | |
| EFNA1 | ephrin-A1 | 0.102 | ||
| FSTL1 | follistatin-like 1 | 0.102 | ||
| MEIS2 | Meis homeobox 2 | 0.102 | ||
| PARVA | parvin, alpha | 0.101 | ||
| FGF8 | fibroblast growth factor 8 (androgen-induced) | 0.098 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.098 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.095 | Mouse | |
| JDP2 | Jun dimerization protein 2 | 0.088 | ||
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.079 | ||
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.078 | ||
| EGR1 | early growth response 1 | 0.078 | Human | |
| FBXW11 | F-box and WD repeat domain containing 11 | 0.077 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.076 | ||
| COL4A6 | collagen, type IV, alpha 6 | 0.076 | Human | |
| TM4SF1 | transmembrane 4 L six family member 1 | 0.076 | ||
| CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | 0.075 | ||
| IQGAP1 | IQ motif containing GTPase activating protein 1 | 0.073 | ||
| PDGFC | platelet derived growth factor C | 0.071 | ||
| MYOD1 | myogenic differentiation 1 | 0.070 | ||
| AR | androgen receptor | 0.070 | Mouse | |
| CHEK2 | CHK2 checkpoint homolog (S. pombe) | 0.069 | ||
| STK3 | serine/threonine kinase 3 | 0.066 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.065 | ||
| MYC | v-myc myelocytomatosis viral oncogene homolog (avian) | 0.065 | Mouse | |
| GSK3B | glycogen synthase kinase 3 beta | 0.064 | ||
| FGF4 | fibroblast growth factor 4 | 0.063 | Human | |
| RB1 | retinoblastoma 1 | 0.063 | ||
| DUSP6 | dual specificity phosphatase 6 | 0.063 | Fly | |
| HOXB5 | homeobox B5 | 0.059 | ||
| GATA4 | GATA binding protein 4 | 0.059 | ||
| ST14 | suppression of tumorigenicity 14 (colon carcinoma) | 0.058 | ||
| BMPR1B | bone morphogenetic protein receptor, type IB | 0.057 | ||
| LUM | lumican | 0.056 | ||
| APC | adenomatous polyposis coli | 0.054 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.054 | ||
| STC1 | stanniocalcin 1 | 0.051 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.051 | ||
| EGFR | epidermal growth factor receptor | 0.051 | ||
| MDM4 | Mdm4 p53 binding protein homolog (mouse) | 0.050 | ||
| CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | 0.050 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.048 | ||
| PLAT | plasminogen activator, tissue | 0.047 | Human | |
| WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.046 | ||
| IL8 | interleukin 8 | 0.045 | ||
| NOTCH3 | notch 3 | 0.045 | ||
| EGR3 | early growth response 3 | 0.045 | Human | |
| PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.044 | ||
| TNC | tenascin C | 0.044 | ||
| FOXD3 | forkhead box D3 | 0.044 | ||
| COL4A5 | collagen, type IV, alpha 5 | 0.044 | Human | |
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.043 | ||
| MSN | moesin | 0.043 | ||
| EDNRA | endothelin receptor type A | 0.042 | Mouse | |
| CXCL12 | chemokine (C-X-C motif) ligand 12 | 0.042 | Mouse | |
| SIM2 | single-minded homolog 2 (Drosophila) | 0.042 | ||
| PKD1 | polycystic kidney disease 1 (autosomal dominant) | 0.042 | ||
| CDH3 | cadherin 3, type 1, P-cadherin (placental) | 0.042 | ||
| S100A4 | S100 calcium binding protein A4 | 0.041 | ||
| CCND1 | cyclin D1 | 0.040 | ||
| CLDN4 | claudin 4 | 0.040 | ||
| DMD | dystrophin | 0.040 | ||
| HNF1A | HNF1 homeobox A | 0.040 | ||
| TP73 | tumor protein p73 | 0.039 | ||
| INHBA | inhibin, beta A | 0.038 | ||
| MKL1 | megakaryoblastic leukemia (translocation) 1 | 0.038 | ||
| UTRN | utrophin | 0.038 | ||
| CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.038 | ||
| PJA1 | praja ring finger 1 | 0.037 | ||
| FOXC2 | forkhead box C2 (MFH-1, mesenchyme forkhead 1) | 0.037 | ||
| S100A2 | S100 calcium binding protein A2 | 0.036 | ||
| EGR2 | early growth response 2 | 0.035 | Human | |
| LAMA4 | laminin, alpha 4 | 0.035 | ||
| SOX1 | SRY (sex determining region Y)-box 1 | 0.035 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.035 | ||
| CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.034 | Fly | |
| CABLES1 | Cdk5 and Abl enzyme substrate 1 | 0.034 | ||
| MSX1 | msh homeobox 1 | 0.033 | ||
| DKK1 | dickkopf homolog 1 (Xenopus laevis) | 0.033 | ||
| FOXF1 | forkhead box F1 | 0.033 | ||
| FOXF2 | forkhead box F2 | 0.032 | Human | |
| TGFB1 | transforming growth factor, beta 1 | 0.032 | Mouse Rat | |
| MEOX1 | mesenchyme homeobox 1 | 0.032 | ||
| PLXNB1 | plexin B1 | 0.031 | ||
| PPM1F | protein phosphatase, Mg2+/Mn2+ dependent, 1F | 0.031 | ||
| FOXA2 | forkhead box A2 | 0.031 | Mouse | |
| CUEDC2 | CUE domain containing 2 | 0.031 | ||
| FGF7 | fibroblast growth factor 7 | 0.030 | Human | |
| HMGA2 | high mobility group AT-hook 2 | 0.030 | ||
| VEGFC | vascular endothelial growth factor C | 0.030 | ||
| JAG2 | jagged 2 | 0.029 | ||
| TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) | 0.029 | ||
| SFRP1 | secreted frizzled-related protein 1 | 0.028 | Mouse | |
| MYOCD | myocardin | 0.028 | ||
| POU5F1 | POU class 5 homeobox 1 | 0.028 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.028 | ||
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.027 | ||
| LAMA5 | laminin, alpha 5 | 0.026 | Mouse | |
| EDN1 | endothelin 1 | 0.026 | Mouse | |
| WT1 | Wilms tumor 1 | 0.026 | ||
| NCOA6 | nuclear receptor coactivator 6 | 0.025 | ||
| HR | hairless homolog (mouse) | 0.025 | ||
| WNT1 | wingless-type MMTV integration site family, member 1 | 0.025 | Mouse Fly | |
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.024 | ||
| PECAM1 | platelet/endothelial cell adhesion molecule | 0.024 | ||
| NRP2 | neuropilin 2 | 0.024 | ||
| SNAI1 | snail homolog 1 (Drosophila) | 0.024 | Fly | |
| PLEC | plectin | 0.024 | Fly | |
| SLIT2 | slit homolog 2 (Drosophila) | 0.024 | ||
| FGF3 | fibroblast growth factor 3 | 0.024 | Human | |
| FYN | FYN oncogene related to SRC, FGR, YES | 0.023 | ||
| TOP1 | topoisomerase (DNA) I | 0.023 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.023 | ||
| C3 | complement component 3 | 0.023 | ||
| SMAD7 | SMAD family member 7 | 0.023 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.022 | Mouse | |
| CYR61 | cysteine-rich, angiogenic inducer, 61 | 0.022 | ||
| CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | 0.022 | ||
| IL6R | interleukin 6 receptor | 0.022 | ||
| CSF1 | colony stimulating factor 1 (macrophage) | 0.022 | Mouse | |
| APOH | apolipoprotein H (beta-2-glycoprotein I) | 0.022 | ||
| A2M | alpha-2-macroglobulin | 0.022 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.022 | ||
| HAS2 | hyaluronan synthase 2 | 0.021 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.021 | ||
| FZD1 | frizzled homolog 1 (Drosophila) | 0.021 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.021 | ||
| IGFBP3 | insulin-like growth factor binding protein 3 | 0.021 | ||
| ROD1 | ROD1 regulator of differentiation 1 (S. pombe) | 0.021 | ||
| SPDEF | SAM pointed domain containing ets transcription factor | 0.021 | ||
| COL7A1 | collagen, type VII, alpha 1 | 0.020 | ||
| PGR | progesterone receptor | 0.020 | Mouse | |
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.020 | ||
| NCOA2 | nuclear receptor coactivator 2 | 0.020 | ||
| PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.020 | ||
| SATB2 | SATB homeobox 2 | 0.020 | ||
| FZD7 | frizzled homolog 7 (Drosophila) | 0.020 | ||
| PRRX1 | paired related homeobox 1 | 0.020 | ||
| RET | ret proto-oncogene | 0.020 | ||
| WFIKKN1 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1 | 0.020 | ||
| PLAU | plasminogen activator, urokinase | 0.019 | Human | |
| VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.019 | Mouse | |
| TGFA | transforming growth factor, alpha | 0.019 | ||
| ENG | endoglin | 0.019 | Mouse | |
| BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.019 | ||
| SH3RF3 | SH3 domain containing ring finger 3 | 0.019 | ||
| COL1A2 | collagen, type I, alpha 2 | 0.019 | ||
| SFN | stratifin | 0.019 | ||
| FOXC1 | forkhead box C1 | 0.019 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.019 | ||
| RNR2 | l-rRNA | 0.018 | ||
| PAX7 | paired box 7 | 0.018 | ||
| PKP3 | plakophilin 3 | 0.018 | ||
| FST | follistatin | 0.018 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.018 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.018 | ||
| INHBB | inhibin, beta B | 0.018 | ||
| F3 | coagulation factor III (thromboplastin, tissue factor) | 0.018 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.017 | ||
| TAOK1 | TAO kinase 1 | 0.017 | ||
| PPARA | peroxisome proliferator-activated receptor alpha | 0.017 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.017 | ||
| SCYL2 | SCY1-like 2 (S. cerevisiae) | 0.017 | ||
| LMX1B | LIM homeobox transcription factor 1, beta | 0.017 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.017 | Mouse | |
| BCL3 | B-cell CLL/lymphoma 3 | 0.017 | ||
| CLDN1 | claudin 1 | 0.017 | ||
| MAGED2 | melanoma antigen family D, 2 | 0.016 | ||
| CLDN7 | claudin 7 | 0.016 | ||
| LBX1 | ladybird homeobox 1 | 0.016 | ||
| EP300 | E1A binding protein p300 | 0.016 | ||
| EFEMP1 | EGF containing fibulin-like extracellular matrix protein 1 | 0.016 | ||
| CHEK1 | CHK1 checkpoint homolog (S. pombe) | 0.016 | ||
| ITGA3 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | 0.016 | ||
| DAXX | death-domain associated protein | 0.016 | ||
| NOTCH1 | notch 1 | 0.016 | Mouse | |
| CARS | cysteinyl-tRNA synthetase | 0.016 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.016 | ||
| MYOG | myogenin (myogenic factor 4) | 0.016 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.016 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.016 | ||
| TBX1 | T-box 1 | 0.015 | ||
| RUNX1T1 | runt-related transcription factor 1; translocated to, 1 (cyclin D-related) | 0.015 | ||
| HBEGF | heparin-binding EGF-like growth factor | 0.015 | ||
| MAPK8 | mitogen-activated protein kinase 8 | 0.015 | ||
| IL1B | interleukin 1, beta | 0.015 | ||
| KRT6C | keratin 6C | 0.015 | ||
| ESR2 | estrogen receptor 2 (ER beta) | 0.015 | ||
| SORBS3 | sorbin and SH3 domain containing 3 | 0.015 | ||
| MYST2 | MYST histone acetyltransferase 2 | 0.015 | ||
| SPARC | secreted protein, acidic, cysteine-rich (osteonectin) | 0.015 | ||
| DDX17 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 17 | 0.015 | ||
| WNT2 | wingless-type MMTV integration site family member 2 | 0.015 | ||
| ARNT | aryl hydrocarbon receptor nuclear translocator | 0.015 | ||
| TFAP2A | transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) | 0.015 | ||
| CACNA1G | calcium channel, voltage-dependent, T type, alpha 1G subunit | 0.014 | ||
| SOCS1 | suppressor of cytokine signaling 1 | 0.014 | ||
| NTRK2 | neurotrophic tyrosine kinase, receptor, type 2 | 0.014 | ||
| ALX4 | ALX homeobox 4 | 0.014 | ||
| HSPG2 | heparan sulfate proteoglycan 2 | 0.014 | ||
| SEMA4A | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A | 0.014 | ||
| YY1 | YY1 transcription factor | 0.014 | ||
| SALL2 | sal-like 2 (Drosophila) | 0.014 | ||
| SHB | Src homology 2 domain containing adaptor protein B | 0.014 | ||
| ITGA8 | integrin, alpha 8 | 0.014 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.014 | ||
| FOXE1 | forkhead box E1 (thyroid transcription factor 2) | 0.014 | ||
| TP53 | tumor protein p53 | 0.014 | ||
| YARS | tyrosyl-tRNA synthetase | 0.014 | ||
| FGF18 | fibroblast growth factor 18 | 0.014 | ||
| TCF7L1 | transcription factor 7-like 1 (T-cell specific, HMG-box) | 0.014 | ||
| WNT3A | wingless-type MMTV integration site family, member 3A | 0.014 | ||
| LATS2 | LATS, large tumor suppressor, homolog 2 (Drosophila) | 0.014 | ||
| LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.013 | ||
| RBPJ | recombination signal binding protein for immunoglobulin kappa J region | 0.013 | ||
| TWSG1 | twisted gastrulation homolog 1 (Drosophila) | 0.013 | ||
| NID1 | nidogen 1 | 0.013 | ||
| TNRC6B | trinucleotide repeat containing 6B | 0.013 | ||
| ZBTB16 | zinc finger and BTB domain containing 16 | 0.013 | ||
| EYA2 | eyes absent homolog 2 (Drosophila) | 0.013 | ||
| FGFR3 | fibroblast growth factor receptor 3 | 0.013 | Fly | |
| GDNF | glial cell derived neurotrophic factor | 0.013 | ||
| NKX3-2 | NK3 homeobox 2 | 0.013 | Human | |
| HOXB13 | homeobox B13 | 0.013 | Mouse | |
| GABPA | GA binding protein transcription factor, alpha subunit 60kDa | 0.013 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.013 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.013 | ||
| MNX1 | motor neuron and pancreas homeobox 1 | 0.013 | ||
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.013 | ||
| AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.013 | ||
| RPS6KA6 | ribosomal protein S6 kinase, 90kDa, polypeptide 6 | 0.013 | ||
| GPC3 | glypican 3 | 0.012 | ||
| PTHLH | parathyroid hormone-like hormone | 0.012 | ||
| NOG | noggin | 0.012 | Mouse | |
| BIK | BCL2-interacting killer (apoptosis-inducing) | 0.012 | ||
| LTBP2 | latent transforming growth factor beta binding protein 2 | 0.012 | ||
| LMO4 | LIM domain only 4 | 0.012 | ||
| NEUROG2 | neurogenin 2 | 0.012 | ||
| CALCA | calcitonin-related polypeptide alpha | 0.012 | ||
| NCK2 | NCK adaptor protein 2 | 0.012 | ||
| CSF2 | colony stimulating factor 2 (granulocyte-macrophage) | 0.012 | ||
| NFIB | nuclear factor I/B | 0.012 | ||
| FZD8 | frizzled homolog 8 (Drosophila) | 0.012 | ||
| THBS2 | thrombospondin 2 | 0.012 | ||
| RNF144B | ring finger protein 144B | 0.012 | ||
| HOXD13 | homeobox D13 | 0.012 | Mouse | |
| FOXA1 | forkhead box A1 | 0.012 | Mouse | |
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.012 | ||
| THBD | thrombomodulin | 0.012 | ||
| CDH6 | cadherin 6, type 2, K-cadherin (fetal kidney) | 0.012 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.012 | ||
| ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.012 | ||
| HOXD10 | homeobox D10 | 0.011 | ||
| SP1 | Sp1 transcription factor | 0.011 | ||
| KRT5 | keratin 5 | 0.011 | ||
| EFNB2 | ephrin-B2 | 0.011 | ||
| CD34 | CD34 molecule | 0.011 | ||
| BCAM | basal cell adhesion molecule (Lutheran blood group) | 0.011 | ||
| MAX | MYC associated factor X | 0.011 | ||
| LAMC1 | laminin, gamma 1 (formerly LAMB2) | 0.011 | ||
| LAMC2 | laminin, gamma 2 | 0.011 | ||
| AGRN | agrin | 0.011 | ||
| PAX6 | paired box 6 | 0.011 | ||
| FNDC3B | fibronectin type III domain containing 3B | 0.011 | ||
| PPP1CC | protein phosphatase 1, catalytic subunit, gamma isozyme | 0.011 | ||
| RARG | retinoic acid receptor, gamma | 0.011 | ||
| NR5A2 | nuclear receptor subfamily 5, group A, member 2 | 0.011 | ||
| NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 | 0.011 | ||
| TNRC6A | trinucleotide repeat containing 6A | 0.011 | ||
| ERG | v-ets erythroblastosis virus E26 oncogene homolog (avian) | 0.011 | ||
| SIX2 | SIX homeobox 2 | 0.011 | Mouse | |
| NKX3-1 | NK3 homeobox 1 | 0.011 | Mouse | |
| LIMK1 | LIM domain kinase 1 | 0.011 | ||
| TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.011 | ||
| SMAD1 | SMAD family member 1 | 0.011 | ||
| CDH2 | cadherin 2, type 1, N-cadherin (neuronal) | 0.011 | ||
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.011 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.011 | ||
| TWIST1 | twist homolog 1 (Drosophila) | 0.011 | ||
| EFNA2 | ephrin-A2 | 0.011 | ||
| RASSF2 | Ras association (RalGDS/AF-6) domain family member 2 | 0.010 | ||
| SOX9 | SRY (sex determining region Y)-box 9 | 0.010 | Mouse | |
| OSMR | oncostatin M receptor | 0.010 | ||
| AMMECR1 | Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 | 0.010 | ||
| IPO8 | importin 8 | 0.010 | ||
| CXCR4 | chemokine (C-X-C motif) receptor 4 | 0.010 | Mouse | |
| ONECUT1 | one cut homeobox 1 | 0.010 | ||
| CAPRIN2 | caprin family member 2 | 0.010 | ||
| LAPTM5 | lysosomal protein transmembrane 5 | 0.010 | ||
| FZD10 | frizzled homolog 10 (Drosophila) | 0.010 | ||
| FRS2 | fibroblast growth factor receptor substrate 2 | 0.010 | Mouse | |
| MKL2 | MKL/myocardin-like 2 | 0.010 | ||
| TGFBI | transforming growth factor, beta-induced, 68kDa | 0.010 | ||
| TFAP2C | transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) | 0.010 | Mouse |